Evidence map›Paper›PMID 25590979›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2015

Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios.

Xiaolin Zhu, Slavé Petrovski, Pingxing Xie, Elizabeth K Ruzzo, Yi-Fan Lu, K Melodi McSweeney, Bruria Ben-Zeev, Andreea Nissenkorn, Yair Anikster, Danit Oz-Levi and 17 more

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 214 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
214citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

214 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. A novel SLC9A1 mutation causes cerebellar ataxia.Journal of human genetics · 2018
    Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Loss of ANK3 Function Causes a Recessive Neurodevelopmental Disorder with Cerebellar Ataxia.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Biallelic MED29 variants cause pontocerebellar hypoplasia with cataracts.European journal of human genetics : EJHG · 2025
    Article
  19. Review
  20. Review

154 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Xiaolin ZhuCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.
Slavé PetrovskiCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.
Pingxing XieCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.
Elizabeth K RuzzoCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.
Yi-Fan LuCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.
K Melodi McSweeneyCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.
Bruria Ben-ZeevEdmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
Andreea NissenkornEdmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
Yair AniksterEdmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
Danit Oz-LeviDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Ryan S DhindsaCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.ORCID http://orcid.org/0000-0002-8965-0813
Yuki HitomiCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.
Kelly SchochDepartment of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
Rebecca C SpillmannCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.
Gali HeimerEdmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
Dina Marek-YagelMetabolic Disease Unit, Edmond and Lily Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
Michal TzadokEdmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
Yujun HanCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.
Gordon WorleyDepartment of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
Jennifer GoldsteinDepartment of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
Yong-Hui JiangDepartment of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
Doron LancetDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Elon PrasEdmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
Vandana ShashiDepartment of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
Duncan McHaleUCB NewMedicines, Slough, UK.ORCID http://orcid.org/0000-0002-3763-4643
Anna C NeedCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.
David B GoldsteinCenter for Human Genome Variation, Duke University School of Medicine, Durham, North Carolina, USA.

Funding

Viral Sequencing CoreU19AI067854 · NIAID · DUKE UNIVERSITY · PI BHARDWAJ, NINA · 2006 to 2011
$290.5M
The Epilepsy Phenome/ Genome Project (EPGP)U01NS053998 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOWENSTEIN, DANIEL H · 2007 to 2013
$26.4M
Comprehensive Sequencing and Analysis of Variation in NHLBI CohortsUC2HL102925 · NHLBI · BROAD INSTITUTE, INC. · PI ALTSHULER, DAVID, GABRIEL, STACEY · 2010 to 2010
$14.7M
Northwest Genomics CenterUC2HL102926 · NHLBI · UNIVERSITY OF WASHINGTON · PI GREEN, PHILIP P, NICKERSON, DEBORAH A · 2010 to 2010
$14.0M
3 of 7 Epi4K: Sequencing, Biostatistics & Bioinformatics CoreU01NS077303 · NINDS · DUKE UNIVERSITY · PI EICHLER, EVAN, GOLDSTEIN, DAVID B. · 2011 to 2018
$13.3M
Northwest Genomics CenterRC2HL102926 · NHLBI · UNIVERSITY OF WASHINGTON · PI GREEN, PHILIP P, NICKERSON, DEBORAH A · 2009 to 2009
$11.0M
Comprehensive Sequencing and Analysis of Variation in NHLBI CohortsRC2HL102925 · NHLBI · BROAD INSTITUTE, INC. · PI ALTSHULER, DAVID, GABRIEL, STACEY · 2009 to 2009
$10.2M
A Large-Scale Schizophrenia Association Study in SwedenR01MH077139 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SULLIVAN, PATRICK F · 2007 to 2018
$9.9M
NEUROPATHOLOGY COREP30AG028377 · NIA · DUKE UNIVERSITY · PI WELSH-BOHMER, KATHLEEN ANNE · 2006 to 2011
$9.6M
Genetics Training Grant-Year 26T32GM007754 · NIGMS · DUKE UNIVERSITY · PI HAASE, STEVEN B · 1985 to 2019
$8.3M
University of Michigan Postbaccalaureate Research Education Program (UM PREP)R25GM086262 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALLEN, BENJAMIN · 2009 to 2024
$6.1M
Whole-genome sequencing for rare highly penetrant gene variants in schizophreniaRC2MH089915 · NIMH · DUKE UNIVERSITY · PI GOLDSTEIN, DAVID B. · 2009 to 2011
$4.6M
NHLBI NIH HHS HL-102923NHLBI NIH HHS HL-102924NHLBI NIH HHS HL-102925NHLBI NIH HHS HL-102926NHLBI NIH HHS HL-103010NHLBI NIH HHS RC2 HL102923NHLBI NIH HHS RC2 HL102924NHLBI NIH HHS RC2 HL102925NHLBI NIH HHS RC2 HL102926NHLBI NIH HHS RC2 HL103010NHLBI NIH HHS UC2 HL102923NHLBI NIH HHS UC2 HL102924NHLBI NIH HHS UC2 HL102925NHLBI NIH HHS UC2 HL102926NHLBI NIH HHS UC2 HL103010NIAID NIH HHS U19 AI067854NIA NIH HHS AG-NS-0441-08NIA NIH HHS P30 AG028377NIGMS NIH HHS R25 GM086262NIGMS NIH HHS T32 GM007754NIMH NIH HHS K01 MH098126NIMH NIH HHS K01MH098126NIMH NIH HHS R01 MH077139NIMH NIH HHS R01MH077139NIMH NIH HHS R01 MH097971NIMH NIH HHS R01MH097971NIMH NIH HHS R01 MH099216NIMH NIH HHS R01MH099216NIMH NIH HHS RC2 MH089915NIMH NIH HHS RC2MH089915NINDS NIH HHS U01 NS053998NINDS NIH HHS U01-NS053998NINDS NIH HHS U01 NS077303NINDS NIH HHS U01-NS077303PHS HHS RCMH089905PHS HHS UO1AIO67854
6 · The paper itself

Abstract

purposeDespite the recognized clinical value of exome-based diagnostics, methods for comprehensive genomic interpretation remain immature. Diagnoses are based on known or presumed pathogenic variants in genes already associated with a similar phenotype. Here, we extend this paradigm by evaluating novel bioinformatics approaches to aid identification of new gene-disease associations.

methodsWe analyzed 119 trios to identify both diagnostic genotypes in known genes and candidate genotypes in novel genes. We considered qualifying genotypes based on their population frequency and in silico predicted effects we also characterized the patterns of genotypes enriched among this collection of patients.

resultsWe obtained a genetic diagnosis for 29 (24%) of our patients. We showed that patients carried an excess of damaging de novo mutations in intolerant genes, particularly those shown to be essential in mice (P = 3.4 × 10(-8)). This enrichment is only partially explained by mutations found in known disease-causing genes.

conclusionThis work indicates that the application of appropriate bioinformatics analyses to clinical sequence data can also help implicate novel disease genes and suggest expanded phenotypes for known disease genes. These analyses further suggest that some cases resolved by whole-exome sequencing will have direct therapeutic implications.

Indexed as

ExomeHigh-Throughput Nucleotide SequencingComputational BiologyFemaleGenetic Association StudiesGenetic Diseases, InbornGenomicsGenotypeHumansMaleMutationPhenotype

Identifiers

PMID25590979
PMCPMC4791490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.